These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10972897)

  • 61. Advances in X-linked immunodeficiency diseases.
    Ochs HD; Aruffo A
    Curr Opin Pediatr; 1993 Dec; 5(6):684-91. PubMed ID: 7907259
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update).
    Cross AR; Noack D; Rae J; Curnutte JT; Heyworth PG
    Blood Cells Mol Dis; 2000 Oct; 26(5):561-5. PubMed ID: 11112388
    [No Abstract]   [Full Text] [Related]  

  • 63. Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient.
    Pérez de Diego R; Bravo J; Allende LM; López-Granados E; Rivera J; Ferreira A; Fontán G; García Rodríguez MC
    Mol Immunol; 2008 Jan; 45(1):301-3. PubMed ID: 17707910
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Iwata T; Kinnon C; Kwan SP; Ochs HD; Vorechovský I; Smith CI
    Nucleic Acids Res; 1996 Jan; 24(1):160-5. PubMed ID: 8594569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disease-causing SAP mutants are defective in ligand binding and protein folding.
    Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
    Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
    Hagemann TL; Chen Y; Rosen FS; Kwan SP
    Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. AQP8 transports NOX2-generated H2O2 across the plasma membrane to promote signaling in B cells.
    Bertolotti M; Farinelli G; Galli M; Aiuti A; Sitia R
    J Leukoc Biol; 2016 Nov; 100(5):1071-1079. PubMed ID: 27256569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Solution structure of the SH3 domain from Bruton's tyrosine kinase.
    Hansson H; Mattsson PT; Allard P; Haapaniemi P; Vihinen M; Smith CI; Hard T
    Biochemistry; 1998 Mar; 37(9):2912-24. PubMed ID: 9485443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.
    Hossle JP; de Boer M; Seger RA; Roos D
    Hum Genet; 1994 Apr; 93(4):437-42. PubMed ID: 8168815
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
    Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK.
    Hussain A; Yu L; Faryal R; Mohammad DK; Mohamed AJ; Smith CI
    FEBS J; 2011 Jun; 278(12):2001-10. PubMed ID: 21518255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. X-linked lymphoproliferative disease: a progressive immunodeficiency.
    Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
    Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency.
    Stewart DM; Notarangelo LD; Kurman CC; Staudt LM; Nelson DL
    J Immunol; 1995 Sep; 155(5):2770-4. PubMed ID: 7650402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Constitutive membrane association potentiates activation of Bruton tyrosine kinase.
    Li T; Rawlings DJ; Park H; Kato RM; Witte ON; Satterthwaite AB
    Oncogene; 1997 Sep; 15(12):1375-83. PubMed ID: 9333013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunodeficiencies caused by genetic defects in protein kinases.
    Notarangelo LD
    Curr Opin Immunol; 1996 Aug; 8(4):448-53. PubMed ID: 8794005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.